Lewy body dementia (LBD) is a complex and often misunderstood condition, marked by overlapping symptoms with Alzheimer's and Parkinson’s disease.
Hosted by CADASIL Consortium, “Unraveling Complexity: Lewy Body Dementia & Biomarker Insights” will explore the latest advances in understanding LBD through the lens of emerging biomarkers.
Featuring Keith N. Fargo, PhD, Director Scientific Initiatives and Julia Wood, MOT, OTR/L, Director of Professional and Community Education, from the Lewy Body Dementia Association, this webinar will provide clarity on how biomarkers are shaping diagnosis, guiding treatment strategies and opening doors to future research.
This webinar is free and open to the public.
For more information, please https://curecadasil.org/cadasil-consortium-march26/
